[Federal Register: May 4, 2009 (Volume 74, Number 84)]
[Notices]               
[Page 20487]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04my09-62]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Evaluation of New Technology To Improve Delivery 
of Immunizations, Funding Opportunity Announcement (FOA) IP09-005 
Initial Review; Development, Implementation and Evaluation of 
Strategies To Increase Vaccination of Adolescents Affiliated With a 
Medical Home, FOA IP09-006 Initial Review; Determine the Impact of 
Strategies To Vaccinate All Children for Influenza in a Practice 
Setting, FOA IP09-007, Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Dates:

8 a.m.-5 p.m., May 21, 2009 (Closed).
8 a.m.-5 p.m., May 22, 2009 (Closed).

    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Evaluation of New Technology 
to Improve Delivery of Immunizations, FOA IP09-005;'' ``Development, 
Implementation and Evaluation of Strategies to Increase Vaccination 
of Adolescents Affiliated with a Medical Home, FOA IP09-006;'' 
``Determine the Impact of Strategies to Vaccinate all Children for 
Influenza in a Practice Setting, FOA IP09-007.''
    Contact Person for More Information: Wendy Carr, PhD, CDC, 1600 
Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 
498-2276.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-10190 Filed 5-1-09; 8:45 am]

BILLING CODE 4163-18-P